The utilisation of chiral coordination complexes as catalysts is referred to as enantioselective catalysis (also known traditionally as asymmetric catalysis). Typically, chiral ligands are used to make the catalysts chiral. The majority of enantioselective catalysts work effectively at low concentrations, making them suitable for synthesis on an industrial scale even when using rare and expensive catalysts. The ability to decrease a range of functional groups by asymmetric hydrogenation makes it one of the most flexible enantioselective synthesis methods. The creation of novel ligands dominates the design of new chiral catalysts. An ion or molecule (functional group) that binds to a main metal atom to create a coordination complex is known as a ligand. Metal catalysed enantioselective synthesis was invented by William S. Knowles and R. Noyori. A significant development in stereo-selective organic synthesis was the discovery of BINAP — Ru (II) complex catalysts. These catalysts have a wide range of potential applications. These chiral Ru complexes function as catalyst precursors for the extremely enantioselective hydrogenation of a variety of, and, — unsaturated carboxylic acids.
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via design-driven bio- and chemical engineering view of biotech
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Application of metal single-site zeolite catalysts in heterogeneous catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Use of iron nanomaterials for the treatment of metals, metalloids and emergent contaminants in water
Marta I Litter, University of General San Martin, Argentina
Title : One-pot multicomponent syntheses of functional chromophores – Synthetic efficiency meets functionality design
Thomas J J Muller, Heinrich-Heine-Universitat Dusseldorf, Germany
Title : From photocatalysis to photon-phonon co-driven catalysis for inert molecules activation
Junwang Tang, Tsinghua University, China
Title : Antibody-proteases as a generation of unique biomarkers, potential targets and translational tools towards design-driven bio- and chemical engineering and personalized and precision medical practice
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico